Comparison of Safety Of Oral Ivermectin with Topical Permethrin in the Treatment of Scabies: A Comparative Study
Introduction: The mite Sarcoptes scabiei var. hominis is the cause of scabies, a skin illness. The Food and Drug Administration (FDA) approves permethrin cream (5%) for the treatment of scabies and is also recommended by the Centers for Disease Control and Prevention (CDC) as first-line topical the...
Saved in:
| Main Authors: | Rishab Dev Tripathee, Seema Sitaula, Sanjeev Kharel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON)
2024-04-01
|
| Series: | Nepal Journal of Dermatology, Venereology & Leprology |
| Subjects: | |
| Online Access: | https://www.nepjol.info/index.php/NJDVL/article/view/62576 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Safety Of Oral Ivermectin with Topical Permethrin in the Treatment of Scabies: A Comparative Study
by: Rishab Dev Tripathee, et al.
Published: (2024-04-01) -
Better Disease Control by Multidrug Regimen in Scabies: A Randomized Controlled Trial
by: Prajwal Pandey, et al.
Published: (2022-09-01) -
Better Disease Control by Multidrug Regimen in Scabies: A Randomized Controlled Trial
by: Prajwal Pandey, et al.
Published: (2022-09-01) -
Pseudoresistance to permethrin in scabies
by: Stefano Veraldi, et al.
Published: (2023-05-01) -
Increase in Scabies Cases and Permethrin Nonresponse in Türkiye
by: Selahattin Aydemir, et al.
Published: (2025-01-01)